Boehringer Ingelheim GmbH

Overview

Boehringer Ingelheim GmbH is a leading research-driven pharmaceutical company that develops innovative solutions for global health. As a privately-owned company, it focuses on human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing.

Therapeutic areas

API / Drug Master Files

Boehringer Ingelheim GmbH holds 0 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ESMOLOL HCLInactive2001-11-30

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Boehringer Ingelheim GmbH in our records. PharmaTek screens the full directory against live FDA enforcement data.